Proposed Spring Summit Agenda...More to come!*
Beware the New Face of Organized Cybersecurity Hackers
The newest internet-enabled global criminals are hidden, well organized, and networked. There is big illegal money to be made in obtaining PHI (protected health information) without consent or the need to know. Nefarious hackers have created a global, profitable, underground market of customers that will pay for PHI.
Given the increasing adoption of mobile and tablet devices by health care providers, even multi-level anti-virus subscriptions are not enough to protect your organization (and your personal liability) from this evolving threat.
Hacking protection is like any other insurance that you need to protect you from liability.
Give your cybersecurity a once-over at this session. Panelists will provide you with pointers and tips to consider when evaluating whether your cybersecurity measures are sufficient.
Keep in Mind – PHI breaches may result in serious regulatory and legal fines.
“How’d You Do It?” Building – and Growing—a Successful Telehealth Program with the Experts
Be honest: part of the reason you go to conferences is to soak up the secrets of the experts. During this hands-on session leaders from some of the country’s top telehealth programs will offer their guidance about:
- Legal and regulatory checklists to guide you in compliance
- Financial viability
- Successful programs of all sizes and models of health providers serving all demographics
- Remote monitoring for chronic conditions in a variety of medical specialties
- What successful start-up strategies look like
- Lessons learned and 20/20 hindsight pointers (to help you avoid unnecessary course-correction costs)
Licensure Impeding Continuity of Care: CTeL’s First Ever All-Hands-on-Deck Debate
Outdated licensure laws are not keeping pace with technology, limiting access to care and impeding continuity of care.
It’s time for a deep-dive-check-up.
Certainly, the Interstate Medical Licensure Compact (IMLC) and the Enhanced Nurse Licensure Compact (eNLC) have moved the needle in the right direction for patient care, but more in-depth analysis of this important treatment issue is needed.
Your viewpoints and expertise are needed in this two-part plenary session to debate the substantive issues surrounding licensure to practice and prescribe.
Session Part One -- Hear two case studies:
- Licensure issues in a behavioral health case and
- Licensure issues in a highly specialized pediatric case.
Session Part Two -- Attendees choose a position on licensure. Attendees will divide into two groups to debate. Pick a team.
- Team A: Licensure attaches to the practitioner’s location. (Meaning: The practitioner only needs a license in the state where she/he is located.)
- Team B: Licensure attaches to the patient’s location (Meaning: The practitioner needs a license in the state where the patient is located at the time of consult.)
Tele-Behavioral Health to the Rescue: Solving the Opioid Epidemic
It’s not hard to overstate the impact that the opioid crisis is having across the U.S.
According to the most recent available data from the Centers for Disease Control and Prevention (CDC) more than 64,000 people died of opioid overdoses in 2016.
Particularly in rural communities, this represents a significant opportunity for expanded use of telemedicine. Unfortunately at the same time, outdated state and federal laws and other restrictions are holding it back, hurting patients and providers alike.
A panel of experts at the CTeL Summit will delve into issues such as:
- The number of addiction treatment facilities in the U.S. means that patients typically need to travel out of state for treatment. Then, once discharged, patients often return home to familiar settings that helped fuel their addiction, making post-discharge follow-up with their treatment providers crucial. While numerous patients could benefit from telemedicine follow-up consults with out-of-state providers, current laws and regulations are standing in the way.
- While the Trump Administration’s public health emergency declaration on opioid addiction did pave the way for telemedicine prescribing of addiction-treatment drugs, this is only a small step in the right direction. What more needs to change?
Hear from the CTeL Controlled Substances Working Group about their work with the Drug Enforcement Administration (DEA) to foster a regulatory climate conducive to solving this national issue.
AI Won't Replace Doctors. But Will Doctors That Embrace AI Replace Doctors Who Don’t?
Artificial intelligence (AI) and its application in predictive health care analytics is poised to be a huge part of the future of care delivery.
Yet, as both simple and complex predictive algorithms weave into diagnoses and treatments augmenting human intervention, legal and regulatory questions will arise:
• What liability does a clinician incur when using predictive analytics?
• How will payers approach predictive analytics?
• What policies and regulations will be put into place?
• Where will mal practice insurers weigh in?
Hear about what expert attorneys, regulatory, and policy folks are forecasting, watching, and thinking about Ai’s game-changing impact on telehealth.
Legislative and Regulatory Update: What’s Happening in Congress and in the States
The 115th Congress, which began in January 2017, has been a particularly active one when it comes to the introduction of telehealth-related legislation. The states, too, have been busy.
- What Congressional bills have been introduced, who and what do they impact, and what are their chances of actually becoming law?
- What significant pieces of proposed (and passed) laws at the state level could map across the country?
Hear from CTeL’s policy research and legal advisory teams, along with Congressional liaisons about the issues to watch.
Advocacy 101: Making Your Voice Heard at the State and Federal Levels
It’s undeniable that this has been a busy Congress when it comes to the introduction of telemedicine legislation. States, too, have been active in this area.
How can members of the telemedicine community help increase the possibility of those bills actually becoming law?
Our expert panelists will outline strategies for reaching out to lawmakers and making a compelling case for telemedicine. Your voice matters, and we’ll show you how to use it.
What Does the Net Neutrality Repeal Mean for Telemedicine?
The repeal of net neutrality is one of the top three issues of all time impacting telemedicine.
In December of 2017, the Federal Communications Commission (FCC) voted 3-2 to overturn a 2015 decision that officially classified the Internet as a public utility and forbade Internet service providers (ISPs) from censoring content. With polls showing the vast majority of Americans in favor of keeping net neutrality intact, millions of people contacted the agency before the vote to voice their support for the 2015 rule.
Telehealth advocates spoke out. They expressed their concern that net neutrality repeal will be a deterrent to the use of telemedicine, particularly in rural communities and critical access hospitals (CAHs)—in other words, places where telemedicine is needed the most.
This issue impacts everyone. BUT if you are a health system, CAH, or a telemedicine vendor this impacts you the most.
During this session you will learn:
- What can telemedicine providers, advocates, and patients expect following the FCC’s vote?
- What legal, regulatory, and policy issues does it raise?
- How might we help make sure providers still feel able to use telemedicine?
- How can we ensure that those who stand to benefit the most from telemedicine still have access to it?
Our expert panelists will provide insights that will allow for feedback and dialogue.
“The Doctor Is In…Your Living Room”: The Concierge Medicine Model
Thanks to companies like Pager, Heal, and even Uber (which has frequently partnered with doctors), the “concierge medicine” model is taking off. What are the pros and cons of this model, and how does it compare to direct-to-consumer telemedicine? What legal, regulatory, and policy concerns are arising as it grows in usage? Let our expert panelists fill you in.
- What types of concierge models are appearing in the marketplace?
- Hear a discussion of the financial features of the concierge model versus the DTC model.
- Why compliance issues need to be the mandatory first step in entering into a concierge style care delivery model, and how compliance can improve profitability.
Fraud and Abuse Under the Microscope
Private payers are seeing an uptick in prescriptions for meds and durable medical equipment. Many of the large private payers have launched investigations. On the public side, in 2017 the OIG announced their own increase in audits.
While your organization may have protocols in place to avert unintentional coding and reimbursement errors, you need to be up-to-speed on what public and private payers are scrutinizing, such as:
- What metrics are payers looking at to determine which audio-video encounters are sufficient for accurate diagnosis, and are eligible?
- How are the unique needs of medical specialties factored in? And, are some specialties under less scrutiny?
- How are payers segmenting reimbursement submissions to predict future payable limits/caps? Perhaps an important coding issue.
Keen focus on cost containment is a priority for all payers. Being well versed in payer concerns is one of the best tools you can have to continue to deliver quality care and be paid for doing so.
e-Prescribing: Legal and Regulatory Hurdles and Analysis
Electronic prescribing (or the secure electronic transmission of prescriptions from a provider to a pharmacy), since it first came into use, has in many ways made both practitioners’ and patients’ lives easier.
At the Summit you will hear:
- How does the process work?
- How are prescriptions actually written?
- What laws and regulations are practitioners bound by, and how might those regulations be improved to meet the realities of the modern era?
Coalition: Coalition: Phase II Research — Discussion on the CTeL Telehealth Reimbursement Coalition
Working Group: Ryan Haight Controlled Substances Working Group
Workshop: Telemedicine — Medicare Reimbursement
*Agenda subject to change.